[Federal Register Volume 84, Number 207 (Friday, October 25, 2019)]
[Notices]
[Pages 57450-57451]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23251]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2018-N-3163; FDA-2012-D-0429; FDA-2012-D-0049; FDA-
2018-N-3031; FDA-2011-D-0125; FDA-2018-N-4428; FDA-2012-N-0560; FDA-
2010-N-0414; FDA-2012-N-1203; and FDA-2019-N-0430]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approvals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is publishing 
a list of information collections that have been approved by the Office 
of Management and Budget (OMB) under the Paperwork Reduction Act of 
1995 (PRA).

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-7726, 
[email protected].

SUPPLEMENTARY INFORMATION: The following is a list of FDA information 
collections recently approved by OMB under section 3507 of the 
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control 
number and expiration date of OMB approval for each information 
collection are shown in table 1. Copies of the supporting statements 
for the information collections are available on the internet at http://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number.

        Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
                                            OMB control    Date approval
           Title of collection                  No.           expires
------------------------------------------------------------------------
Physician Interpretation of Information        0910-0875       9/30/2021
 About Prescription Drugs in Scientific
 Publications Versus Promotional Pieces.
Guidance on Meetings with Industry and         0910-0731       8/31/2022
 Investigators on the Research and
 Development of Tobacco Products........

[[Page 57451]]

 
Reporting Harmful and Potentially              0910-0732       8/31/2022
 Harmful Constituents in Tobacco
 Products and Tobacco Smoke Under the
 Federal Food, Drug, and Cosmetic Act...
Tobacco Products, User Fees,                   0910-0749       8/31/2022
 Requirements for the Submission of Data
 Needed to Calculate User Fees for
 Domestic Manufacturers and Importers of
 Tobacco................................
Guidance for Industry on Establishing          0910-0775       8/31/2022
 That a Tobacco Product Was Commercially
 Marketed in the United States as of....
February 15, 2007.......................
Medicated Feed Mill License Application.       0910-0337       9/30/2022
Guidance on Informed Consent for In            0910-0582       9/30/2022
 Vitro Diagnostic Studies Using Leftover
 Human Specimens That Are Not
 Individually Identifiable..............
Manufactured Food Regulatory Program           0910-0601       9/30/2022
 Standards..............................
Information to Accompany Humanitarian          0910-0661       9/30/2022
 Device Exemption Applications and
 Annual Distribution Number Reporting
 Requirements...........................
Generic Clearance for Quick Turnaround         0910-0876       9/30/2022
 Testing of Communication Effectiveness.
------------------------------------------------------------------------


    Dated: October 17, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-23251 Filed 10-24-19; 8:45 am]
 BILLING CODE 4164-01-P